QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.014449v1 68/4/1183    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, T.-H. Articles by Chen, J.-J. Search for Related Content PubMed PubMed Citation Articles by Cheng, T.-H. Articles by Chen, J.-J.

Nitric Oxide Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy through cGMP-mediated Suppression of Extracellular-Signal Regulated Kinase Phosphorylation

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (J.-J.C.); Department of Medicine, Taipei Medical University-Wan Fang Medical Center, Taipei, Taiwan (T.-H.C., J.-W.L., Y.-L.C., C.-H.C., W.-T.C.); Department of Life Science, National University of Kaohsiung, Kaohsiung, Taiwan (N.-L.S.); Department of Pediatrics, Tzu Chi Buddhist General Hospital, Hualien, Taiwan (C.-F.C.); University of British Columbia, Vancouver, British Columbia, Canada (S.-Y.C.); and Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (Y.-L.C., H.L., S.-Y.C., C.-F.C., D.L.W., J.-J.C.)

Cardiac hypertrophy is a compensatory mechanism in response to a variety of cardiovascular diseases. Recently, reactive oxygen species and nitric oxide (NO) have been demonstrated to be involved in the pathogenesis of atherosclerosis; however, the role of these free radicals in the development of cardiac hypertrophy remains unclear. In this study, we investigate NO modulation of cellular signaling in endothelin-1 (ET-1)-induced cardiomyocyte hypertrophy in culture. ET-1 treatment of cardiomyocytes increased constitutive NO synthase activity and induced NO production via the stimulation of ET-receptor subtype ET_B. Using Northern blot analysis and chloramphenicol acetyltransferase assay, we found that NO suppressed the ET-1-induced increase in c-fos mRNA level and promoter activity. In contrast, ET-1 stimulation of c-fos expression was augmented by depletion of endogenous NO generation with the addition of NO scavenger PTIO into cardiomyocytes. Cells cotransfected with the dominant negative and positive mutants of signaling molecules revealed that the Ras/Raf/extracellular-signal regulated kinase (ERK) signaling pathway is involved in ET-induced c-fos gene expression. Furthermore, NO directly inhibited ET-1-induced ERK phosphorylation and activation in a cGMP-dependent manner, indicating that NO modulates ET-1-induced c-fos expression via its inhibitory effect on ERK signaling pathway. The ET-1-stimulated activator protein-1 (AP-1) DNA binding activity and AP-1-mediated reporter activity were attenuated by NO. In addition, NO also significantly inhibited ET-1-stimulated promoter activity of hypertrophic marker gene -myosin heavy chain and the enhanced protein synthesis. Taken together, our findings provide the molecular basis of NO as a negative regulator in ET-1-induced cardiac hypertrophy.

Address correspondence to: Dr. Jin-Jer Chen, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10051, Taiwan, R.O.C. E-mail: jamesjc{at}ibms.sinica.edu.tw

This article has been cited by other articles:

				G. Ruiz-Hurtado, M. Fernandez-Velasco, M. Mourelle, and C. Delgado LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation Hypertension, December 1, 2007; 50(6): 1049 - 1056. [Abstract] [Full Text] [PDF]

				A. Bouallegue, G. B. Daou, and A. K. Srivastava Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2072 - H2079. [Abstract] [Full Text] [PDF]